E-ISFA 2020 Announcement

3rd Congress of the European Group – International Society for Apheresis (E-ISFA)

Dresden, March 19 to 21, 2020

Congress Topics

  • Recent progress in lipoprotein apheresis
    • Homozygous familial hypercholesterolemia
    • Lipoprotein(a)
    • Competition with drugs
  • Plasma exchange
  • Immunoadsorption – indications, results, future perspectives
  • Experience with extracorporeal therapy in children and during pregnancy
  • Apheresis Registries
  • How to assure the quality of care in extracorporeal therapy
  • Psychosocial aspects in patients undergoing extracorporeal therapy
  • Apheresis in transplantation
  • New developments
    • Specific elimination of C-reactive Protein
      • After myocardial infarction, after other diseases
    • Other new devices
  • Extracorporeal Photopheresis
  • Cellular Therapies
  • Actual aspects of lipid-lowering therapy
    • New data on PCSK9 inhibitors
    • Antisense oligonucleotides against apolipoprotein CIII and apolipoprotein(a)
    • Bempedoic acid – current status
    • New preparations of omega-3 fatty acids
    • Lomitapide
    • Latest study data

Further activities

  • Sessions for medical staff (mostly in German)
    • Role of the medical staff in an Apheresis center
    • Psychological aspects
    • Venous access problems
    • Problems when treating children
    • Different apheresis methods – advantages, disadvantages
    • Other developments
  • Special sessions organized by the industry (experience with apheresis devices, actual recommendations, troubleshooting)
  • Actual topics in lipidology (in German, on Friday, March 20, 2018 in the afternoon, free entrance to all people wishing to attend)

Further information will follow in spring 2019

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.